Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/3458
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMukharram A.Musaeva, Dinara A.Parpibaeva, Muborak S.Salaeva, Nargiza D.Salimova-
dc.date.accessioned2022-10-12T04:15:56Z-
dc.date.available2022-10-12T04:15:56Z-
dc.date.issued2022-
dc.identifier.issn2643-9840, 2643-9875-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/3458-
dc.description.abstractToday, diabetes mellitus is one of the most powerful risk factors for the development of cardiovascular diseases and its complications. [1] In 50% of patients with type 1 diabetes and in 80% of people with type 2 diabetes, early disability and premature death are recorded due to cardiovascular complications. People with diabetes are often at risk for strokes, heart attacks, and high blood pressure. In this regard, the main strategy for the treatment of patients with diabetes is to prevent the development of cardiovascular complications, which includes strict control of glycemia, blood pressure, as well as antiplatelet and lipid-lowering therapy.en_US
dc.language.isoen_USen_US
dc.publisherUSAen_US
dc.subjectdipeptidyl peptidase-4 inhibitors, metformin, type 2 diabetes mellitus, heart failure, average ejection fraction, preserved ejection fraction, lipid spectrum, statinen_US
dc.titleRelationships Between the Achieved Target Levels of LDL Cholesterol and the State of Various Types of LV EF in Patients with Coronary Artery Disease and Type 2 Diabetesen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
5.May-2pdf.com-extract.pdfRelationships Between the Achieved Target Levels of LDL Cholesterol and the State of Various Types of LV EF in Patients with Coronary Artery Disease and Type 2 Diabetes.1.37 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.